NCT06547879

Brief Summary

This randomized controlled study evaluated an education program based on the Roper, Logan, and Tierney model of daily living activities, supported by mindfulness, for hypertensive individuals. The intervention group received eight weeks of online sessions, while the control group received routine care. Results showed significant improvements in systolic and diastolic blood pressure, self-care, treatment adherence, and healthy lifestyle behaviors in the intervention group compared to controls (p\<0.05). Findings suggest that mindfulness-supported education enhances hypertension management. Further studies with larger samples and long-term follow-up are recommended.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 4, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

2 months

First QC Date

August 4, 2024

Last Update Submit

August 8, 2024

Conditions

Keywords

Daily living activitieseducationhealthy livinghypertensionmindfulnessself-caretreatment adherence

Outcome Measures

Primary Outcomes (4)

  • Hypertension Self-Care Profile

    The Hypertension Self-Care Profile Scale has three subscales: behavior, motivation and self-efficacy. In this scale, each sub-dimension is evaluated separately and a total of minimum 20 and maximum 80 points can be obtained from the scale. Higher scores indicate better self-care.

    At week 0, week 8 and week 12

  • Hill-Bone Hypertension Treatment Compliance Scale

    The scale consists of three sub-dimensions (interview, medical and nutrition) and a total of 14 questions. The total score that can be obtained from the scale varies between 14 and 56; A score of 14 indicates full compliance, while higher scores indicate treatment non-compliance.

    At week 0, week 8 and week 12

  • Healthy Lifestyle Behaviors Scale II

    It aims to evaluate individuals' behaviors towards healthy lifestyles. There are 52 items in total in the scale, and all of the items consist of positive expressions. The minimum score that can be obtained from the scale is 52 and the maximum score is 208.

    At week 0, week 8 and week 12

  • Conscious awareness

    It evaluates individual differences in individuals' states of consciousness and measures their tendency to be aware of and pay attention to momentary experiences in daily life. The total score that can be obtained varies between 15 and 90. A high score indicates a high level of conscious awareness.

    At week 0, week 8 and week 12

Secondary Outcomes (3)

  • Systolic and diastolic blood pressure

    At week 0, week 8 and week 12

  • Metabolic Control Variables

    At week 0 and week 8

  • Hypertension Information Assessment

    At week 0 and week 8

Study Arms (2)

Intervention group

EXPERIMENTAL

One session per week; 20 minutes for the training module and 25 minutes for the awareness practice, a total of 45 minutes each week, for a total of 8 weeks.

Behavioral: Hypertension Self Management Program

Control group

NO INTERVENTION

Usual care.

Interventions

The HT self-management training program was continued in the form of one session per week, a total of 8 modules, for 8 weeks, with different module content each week. After these eight-week training and awareness sessions were completed, the implementation of the study was terminated (week 8), no additional intervention was given to the intervention group, and the evaluations at the 8th week (end of intervention-T1) and the 12th week (follow-up-T2) were carried out by the researcher during the routine checks of the participants at the outpatient clinic. It was carried out face to face.

Intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 65
  • Literate (able to read and write)
  • Followed up for at least 6 months with a diagnosis of stage 1 primary hypertension (HT)
  • Taking at least one antihypertensive medication
  • No changes in antihypertensive medication in the past month
  • Able to use a smartphone and WhatsApp® application
  • Having internet access and willing to participate in online sessions

You may not qualify if:

  • Those with hearing and vision problems
  • Those with cognitive impairment
  • Having a psychiatric diagnosis such as major depression
  • Having a history of major heart surgery in the last 6 months
  • Those with severe symptom burden due to advanced COPD, heart failure, asthma, cancer
  • Individuals who used another mind-body-based approach (yoga, meditation, relaxation exercise, etc.) during the research were not included in the sample.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ornek Mahallesi, 2061. Caddesi 4/1 Blok No:37

Altındağ, Ankara, 06080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

HypertensionCardiovascular DiseasesTreatment Adherence and ComplianceHealth Behavior

Condition Hierarchy (Ancestors)

Vascular DiseasesBehavior

Study Officials

  • Hacer Eroğlu

    haceroturmaz@hacettepe.edu.tr

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Blinding of Participants: Blinding of participants means that the individuals taking part in the study are not aware of which group they have been assigned to, whether it is the intervention group or the control group. This helps to prevent bias in their behavior and responses, as they do not know if they are receiving the actual treatment or a placebo. Blinding of Outcome Assessors: Blinding of outcome assessors involves keeping the individuals who are measuring and assessing the results of the study unaware of which participants belong to the intervention or control group. This is done to ensure that the data collected and the evaluations made are not influenced by any preconceived notions or expectations about the effectiveness of the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study has a parallel two-group, randomized controlled intervention design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctoral Student

Study Record Dates

First Submitted

August 4, 2024

First Posted

August 9, 2024

Study Start

March 15, 2023

Primary Completion

May 15, 2023

Study Completion

July 5, 2024

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Researchers interested in accessing the IPD should contact the study's principal investigator via email at \[email address\]. Requests will be reviewed and responded to within four weeks.

Locations